Recombinant Adenosine A2a Receptor antibody

Catalog No. ABIN7072300

This Mouse Chimeric antibody specifically detects Adenosine A2a Receptor in ELISA and BP. It exhibits reactivity toward Human.

Quick Overview for Recombinant Adenosine A2a Receptor antibody (ABIN7072300)

Target: Adenosine A2a Receptor (ADORA2A)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Chimeric

Conjugate: This Adenosine A2a Receptor antibody is un-conjugated

Application: ELISA, Blocking Peptide (BP)

Clone: Ig2838

Product Details anti-Adenosine A2a Receptor Antibody

Purpose: Anti-A2A-Adenosine Receptor [Ig2838], Mouse IgG1, kappa

Specificity:

This antibody binds specifically to the human A2 adenosine receptor.

Application Notes original Clone: This antibody binds to the A2 adenosine receptor, a G-protein-coupled receptor for adenosine that, upon ligand binding, activates adenylyl cyclase. The antibody acts as an allosteric inhibitor.

Characteristics: This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Purification: Protein A affinity purified

Immunogen: Human recombinant A2-adenosine receptor.

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

OriginalSpeciesName: Mouse

OriginalFormat: IgG1

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for Adenosine A2a Receptor

Target: Adenosine A2a Receptor (ADORA2A)

Alternative Name: A2A-Adenosine Receptor

Background: ADORA2A

UniProt: P29274

Pathways: Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints